When to Discuss a Dosage Change You may need to review your dosage with your provider if: You experience persistent swelling, numbness, or tingling IGF-1 or glucose levels move outside your target range Youre not seeing expected results after several months of consistent use Providers may adjust the timing, switch formulations, or combine tesamorelin with peptides such as CJC-1295 or Ipamorelin for synergistic effects
Yes, both contain the identical active ingredient tirzepatide at the same dosage strengths, but they have different FDA-approved indicationsMounjaro for type 2 diabetes and Zepbound for chronic weight managementand should not be substituted without prescriber direction
American Journal of Cardiovascular Drugs
| Life & Style Weekly
This is the trap that leads to rapid weight regain if you ever stop the medication
Some of the health problems that are caused by being obese are high cholesterol, high blood pressure, sleep apnea, and heart disease to name a few
